MASSDEVICE ON CALL — Technology giant Samsung (LON:BC94) announced new healthcare features for upcoming models of its Gear smartphone-connected watches, which will include heart rate sensors and the company’s FDA-cleared S Health app.

The new Gear 2 and Gear 2 Neo models will be on the shelves in April, MobiHealthNews reported.

The heart-rate sensor is a new addition, but the S Health app has been available on U.K. smartphones since 2012. The app allows users to integrate a variety of healthcare metrics, including readings from Lifescan’s OneTouch blood glucose meters and other devices. The app won FDA clearance in January.

The announcement comes as rival smartphone technologies maker Apple Inc. (NSDQ:AAPL) remains mum on growing rumors of interest in medical devices and rumors of a sensor to predict heart attacks.

 Early action key in preventive ovarian surgery, docs say
Doctors for the 1st time moved to recommend early preventive surgery removal for women found to have a BRCA1 genetic mutation, calling for surgery before the age of 35 in order to reduce the risk of ovarian cancer.  
Read more

 Abbott boosts pension contributions by $300M
Medical device maker Abbott Labs (NYSE:ABT) announces plans to add about $400 million to its post-retirement coffers, most of which will go to a domestic pension fund.  
Read more

 Curbing enthusiasm for electronic medical records
Regulators are pushing too hard and too fast on electronic health records, potentially derailing efforts at a nationwide transition by setting expectations that healthcare groups can’t meet.  
Read more

 Interoperability tops healthcare’s IT priorities
A survey of more than 140 healthcare leaders finds that technology interoperability is the top investment area for healthcare executives, followed by mobile connectivity and point-of-care devices.
Read more